Doxorubicin Induces Apoptosis through down Regulation of miR-21 Expression and Increases miR-21 Target Gene Expression in MCF-7 Breast Cancer Cells

Journals Menu

Follow SCIRP

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

"Doxorubicin Induces Apoptosis through down Regulation of miR-21 Expression and Increases miR-21 Target Gene Expression in MCF-7 Breast Cancer Cells"
written by Roghayeh Tofigh, Saeedeh Akhavan, Nastaran Tarban, Amin Ebrahimi Sadrabadi, Arsalan Jalili, Kaykhosro Moridi, Sara Tutunchi,
published by International Journal of Clinical Medicine, Vol.8 No.6, 2017

has been cited by the following article(s):

[1]	Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence
	Journal of Drug Delivery …, 2022

[2]	Combination of Doxorubicin and Berberine Generated Synergistic Anticancer Effect on Breast Cancer Cells Through Down-regulation of Nanog and miRNA-21 Gene …
	2020

[3]	Effect of Platelet Releasate on uPA and uPAR Gene Expression in Mesenchymal Stem Cells
	2020

[4]	The Regulatory Role of Differential Expressed MicroRNAs and Viral Oncoproteins in Angiogenesis of Human Papillomavirus-Related Cancer
	2019

[5]	Assessing the frequency of t (12; 21)(p13; q22) in patients with acute lymphoblastic leukemia in northeastern of Iran
	2018

[1]	MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology Pathology - Research and Practice, 2024 DOI:10.1016/j.prp.2024.155091

[2]	Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence Journal of Drug Delivery Science and Technology, 2022 DOI:10.1016/j.jddst.2021.102984

[3]	Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence Journal of Drug Delivery Science and Technology, 2022 DOI:10.1016/j.jddst.2021.102984

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top